Host-Directed Therapy in Pandemic Preparedness

JAMA. 2025 Feb 25;333(8):661-662. doi: 10.1001/jama.2024.26152.

Authors

Mihai G Netea^{1

2}, Frank L van de Veerdonk¹, Evangelos J Giamarellos-Bourboulis^{3

4}

Affiliations

¹ Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
² Department of Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, Germany.
³ 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Greece.
⁴ Hellenic Institute for the Study of Sepsis, Athens, Greece.

PMID: 39761040
DOI: 10.1001/jama.2024.26152

No abstract available

Plain language summary

This JAMA Viewpoint explores the addition of host-directed therapy using immunotherapeutic agents to pandemic preparedness programs.